bg
A

Anaptysbio (ANAB)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Anaptysbio (ANAB)

AnaptysBio, Inc. is a clinical stage biotechnology company. The Company is developing immunology therapeutic product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops its ... Read more

  • USD18.09
  • USD18.09
  • USD17.43
  • USD32.44
  • -9.20%
  • 13M
  • 182.01k
  • 306.59k
  • 448M
  • 16.51
  • -31.10%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.